Hatta Y, Itoh T, Baba M, Izumi T, Sasaki I, Shimojima H, Miyajima T, Aizawa S, Takeuchi J, Horikoshi A, Ohshima T, Sawada U, Amemiya Y, Horie T
First Department of Internal Medicine, Nihon University School of Medicine.
Rinsho Ketsueki. 1998 Sep;39(9):645-51.
Twenty-one patients, aged 16-41 years, were prospectively followed for pulmonary function prior to and up to nine months after bone marrow transplantation (BMT). All patients had normal radiographs and no clinical signs of pulmonary disease. The FEV1.0%, V25, and of V50/V25 were within the normal ranges for all patients. Percent vital capacity (%VC) and percent diffusing capacity of lung for CO (% DLco) dropped progressively in most of the patients up to 9 months following BMT. Pulmonary function decreased earlier in patients with GVHD as well as patients who received total body irradiation either at a high dose rate (10 cGy/min) or a high lung dose (12 Gy). These asymptomatic declines in pulmonary function were measured by frequent tests of lung function.
对21名年龄在16至41岁之间的患者进行了前瞻性研究,在骨髓移植(BMT)前及移植后长达9个月的时间里监测其肺功能。所有患者的胸部X光片均正常,且无肺部疾病的临床症状。所有患者的第一秒用力呼气容积百分比(FEV1.0%)、25%肺活量(V25)以及V50/V25均在正常范围内。在大多数患者中,直至BMT后9个月,肺活量百分比(%VC)和一氧化碳肺弥散量百分比(%DLco)逐渐下降。移植物抗宿主病(GVHD)患者以及接受高剂量率(10 cGy/分钟)全身照射或高肺剂量(12 Gy)照射的患者肺功能下降更早。通过频繁的肺功能测试来检测这些无症状的肺功能下降情况。